Master One Thing - Rapamycin Longevity Series cover image

Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging

Master One Thing - Rapamycin Longevity Series

00:00

When Joan Would Personally Take a Rapalog

Joan says she'd wait for human data on dose, duration, and safety before taking a TORC1-selective rapalog herself.

Play episode from 01:11:54
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app